Christoph E Hagemeyer Selected Research

Oxygen (Dioxygen)

1/2021

Effects of water stably-enriched with oxygen as a novel method of tissue oxygenation on mitochondrial function, and as adjuvant therapy for type 2 diabetes in a randomized placebo-controlled trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Christoph E Hagemeyer Research Topics

Disease

23	Thrombosis (Thrombus) 01/2023 - 07/2006
8	Hemorrhage 01/2023 - 07/2006
7	Neoplasms (Cancer) 04/2024 - 01/2015
5	Atherosclerosis 04/2020 - 07/2009
4	Inflammation (Inflammations) 09/2019 - 06/2009
4	Carotid Artery Thrombosis 01/2018 - 05/2007
4	Ischemia 01/2018 - 09/2011
3	Fibrosis (Cirrhosis) 04/2024 - 01/2021
3	Myocardial Infarction 10/2017 - 01/2010
2	Thrombocytopenia (Thrombopenia) 01/2023 - 01/2022
2	Ischemic Stroke 01/2023 - 01/2022
2	Stroke (Strokes) 01/2023 - 07/2020
2	Cardiovascular Diseases (Cardiovascular Disease) 04/2020 - 07/2017
2	Atherosclerotic Plaque (Atheroma) 05/2011 - 07/2009
1	Hematologic Neoplasms (Hematological Malignancy) 12/2023
1	Hyperglycemia 05/2023
1	Hypoglycemia (Reactive Hypoglycemia) 05/2023
1	Heart Failure 01/2023
1	Critical Illness (Critically Ill) 01/2023
1	Thromboinflammation 01/2023
1	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 01/2023
1	Intracranial Hemorrhages (Intracranial Hemorrhage) 01/2023
1	Cicatrix (Scar) 01/2022
1	Thrombotic Thrombocytopenic Purpura 01/2022
1	Diabetes Mellitus 01/2021
1	Type 2 Diabetes Mellitus (MODY) 01/2021
1	Insulin Resistance 01/2021
1	Cardiomyopathies (Cardiomyopathy) 01/2021
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2021
1	Vascular System Injuries 01/2019
1	Vascular Diseases (Vascular Disease) 01/2018
1	Venous Thromboembolism 01/2018
1	Myocardial Ischemia (Ischemic Heart Diseases) 10/2017
1	Infarction (Infarctions) 10/2017

Drug/Important Bio-Agent (IBA)

6	Fibrinolytic Agents (Antithrombotic Agents)IBA 01/2023 - 03/2007
6	ferric chlorideIBA 01/2016 - 07/2006
5	Glycoproteins (Glycoprotein)IBA 01/2023 - 06/2012
4	Proteins (Proteins, Gene)FDA Link 12/2023 - 09/2011
4	AnticoagulantsIBA 01/2023 - 03/2007
4	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 01/2023 - 06/2012
4	LigandsIBA 11/2022 - 01/2010
3	Peptides (Polypeptides)IBA 04/2024 - 01/2021
3	Plasminogen Activators (Plasminogen Activator)IBA 01/2023 - 09/2015
3	von Willebrand FactorIBA 01/2022 - 01/2019
3	Contrast MediaIBA 07/2017 - 05/2011
3	Thrombin FDA Link 01/2016 - 01/2015
3	Single-Chain AntibodiesIBA 03/2014 - 03/2007
2	NisinIBA 04/2024 - 11/2022
2	Molecular Probes (Molecular Probe)IBA 04/2024 - 04/2020
2	CollagenIBA 04/2024 - 01/2021
2	Chelating AgentsIBA 12/2023 - 01/2015
2	Glucose (Dextrose)FDA LinkGeneric 05/2023 - 10/2017
2	PlasminogenIBA 11/2022 - 03/2014
2	EpitopesIBA 03/2011 - 05/2007
2	IntegrinsIBA 01/2010 - 07/2009
2	FibrinIBA 06/2009 - 03/2007
2	Immunoglobulin FragmentsIBA 06/2009 - 03/2007
1	Chimeric Antigen ReceptorsIBA 12/2023
1	Radioisotopes (Radionuclides)IBA 12/2023
1	Insulin (Novolin)FDA Link 05/2023
1	Tenecteplase FDA Link 01/2023
1	VaccinesIBA 01/2023
1	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2023
1	Antiviral Agents (Antivirals)IBA 01/2023
1	Immunosuppressive Agents (Immunosuppressants)IBA 01/2023
1	Immunoglobulin G (IgG)IBA 11/2022
1	caplacizumabIBA 01/2022
1	Fibrinogen (Factor I)FDA Link 01/2022
1	GadoliniumIBA 01/2022
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2022
1	thiamine triphosphorate (TTP)IBA 01/2022
1	Oxygen (Dioxygen)IBA 01/2021
1	Drinking WaterIBA 01/2021
1	Liposomes (Liposome)IBA 07/2020
1	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 09/2019
1	aspartylglycineIBA 01/2019
1	Hemostatics (Antihemorrhagics)IBA 01/2019
1	Cyclic PeptidesIBA 01/2019
1	Ethylene Glycol (Monoethylene Glycol)IBA 01/2019
1	HDL LipoproteinsIBA 10/2017
1	Hydrogen Sulfide (Sulfide, Hydrogen)IBA 08/2017
1	ProdrugsIBA 08/2017
1	Cisplatin (Platino)FDA LinkGeneric 08/2017
1	AntigensIBA 07/2017
1	ferric oxide (iron oxide)IBA 07/2017
1	Fatty Acid-Binding ProteinsIBA 12/2016
1	Biomarkers (Surrogate Marker)IBA 12/2016
1	Evans Blue (Blue, Evans)FDA Link 12/2016
1	Fatty Acid Binding Protein 3IBA 12/2016
1	Troponin IIBA 12/2016

Therapy/Procedure

11	Therapeutics 01/2022 - 01/2010
2	Microbubbles 01/2016 - 06/2012
2	Percutaneous Coronary Intervention 03/2014 - 01/2010
1	Immunotherapy 12/2023
1	Extracorporeal Membrane Oxygenation 01/2023
1	Membrane Oxygenators (Membrane Oxygenator) 01/2023
1	Emergency Treatment 01/2023
1	Surgical Instruments (Clip) 01/2022
1	Hyperbaric Oxygenation 01/2021
1	Nanospheres 07/2020